{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:31:38Z","timestamp":1790811098430,"version":"4.1.0"},"reference-count":35,"publisher":"Society of Nuclear Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.2967\/jnumed.122.265095","type":"journal-article","created":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T15:35:54Z","timestamp":1687448154000},"page":"1439-1445","source":"Crossref","is-referenced-by-count":20,"title":["Efficacy of HER2-Targeted Intraperitoneal<sup>225<\/sup>Ac \u03b1-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal Carcinomatosis"],"prefix":"10.2967","volume":"64","author":[{"given":"Sebastian K.","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Burnes","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"Chandler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumudu","family":"Katugampola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren R.","family":"Veach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"McDevitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin H.","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett A.","family":"Vaughn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara S.","family":"Rinne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blesida","family":"Punzalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Fen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pat B.","family":"Zanzonico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Monette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangbin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ouathek","family":"Ouerfelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrett M.","family":"Nash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cercek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward K.","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger W.","family":"Howell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Cheal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nai-Kong V.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2023,6,22]]},"reference":[{"key":"2023091409501492000_64.9.1439.1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492"},{"key":"2023091409501492000_64.9.1439.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2013.10.001"},{"key":"2023091409501492000_64.9.1439.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(88)80281-8"},{"key":"2023091409501492000_64.9.1439.4","doi-asserted-by":"crossref","first-page":"100624","DOI":"10.1016\/j.adro.2020.11.009","article-title":"Palliative radiation therapy for metastatic, persistent, or recurrent epithelial ovarian cancer: efficacy in the era of modern technology and targeted agents","volume":"6","author":"Butala","year":"2020","journal-title":"Adv Radiat Oncol."},{"key":"2023091409501492000_64.9.1439.5","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/852748"},{"key":"2023091409501492000_64.9.1439.6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.10.104"},{"key":"2023091409501492000_64.9.1439.7","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1995.9969"},{"key":"2023091409501492000_64.9.1439.8","doi-asserted-by":"crossref","first-page":"100787","DOI":"10.1016\/j.gore.2021.100787","article-title":"Ovarian cancer with high-level focal ERBB2 amplification responds to trastuzumab and pertuzumab","volume":"37","author":"Thouvenin","year":"2021","journal-title":"Gynecol Oncol Rep."},{"key":"2023091409501492000_64.9.1439.9","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3925"},{"key":"2023091409501492000_64.9.1439.10","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3390\/pharmaceutics11090434","article-title":"Therapeutic applications of pretargeting","volume":"11","author":"Verhoeven","year":"2019","journal-title":"Pharmaceutics."},{"key":"2023091409501492000_64.9.1439.11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s41181-017-0026-8","article-title":"Pretargeting for imaging and therapy in oncological nuclear medicine","volume":"2","author":"Bailly","year":"2017","journal-title":"EJNMMI Radiopharm Chem."},{"key":"2023091409501492000_64.9.1439.12","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262186"},{"key":"2023091409501492000_64.9.1439.13","doi-asserted-by":"crossref","first-page":"5106","DOI":"10.7150\/thno.26585","article-title":"Theranostic pretargeted radioimmunotherapy of internalizing solid tumor antigens in human tumor xenografts in mice: curative treatment of HER2-positive breast carcinoma","volume":"8","author":"Cheal","year":"2018","journal-title":"Theranostics."},{"key":"2023091409501492000_64.9.1439.14","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-21-0353"},{"key":"2023091409501492000_64.9.1439.15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev-bioeng-062117-120931","article-title":"Targeted and nontargeted alpha-particle therapies","volume":"20","author":"McDevitt","year":"2018","journal-title":"Annu Rev Biomed Eng."},{"key":"2023091409501492000_64.9.1439.16","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004110945"},{"key":"2023091409501492000_64.9.1439.17","doi-asserted-by":"crossref","first-page":"11359","DOI":"10.7150\/thno.48810","article-title":"Alpha radioimmunotherapy using 225Ac-proteus-DOTA for solid tumors: safety at curative doses","volume":"10","author":"Cheal","year":"2020","journal-title":"Theranostics."},{"key":"2023091409501492000_64.9.1439.18","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1021\/acs.bioconjchem.9b00736","article-title":"An N-acetylgalactosamino dendron-clearing agent for high-therapeutic-index DOTA-hapten pretargeted radioimmunotherapy","volume":"31","author":"Cheal","year":"2020","journal-title":"Bioconjug Chem."},{"key":"2023091409501492000_64.9.1439.19","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(81)90703-X"},{"key":"2023091409501492000_64.9.1439.20","doi-asserted-by":"publisher","DOI":"10.1016\/0960-0760(95)00187-5"},{"key":"2023091409501492000_64.9.1439.21","doi-asserted-by":"crossref","first-page":"e1267891","DOI":"10.1080\/2162402X.2016.1267891","article-title":"Overcoming resistance to HER2-targeted therapy with a novel HER2\/CD3 bispecific antibody","volume":"6","author":"Lopez-Albaitero","year":"2017","journal-title":"OncoImmunology."},{"key":"2023091409501492000_64.9.1439.22","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-13-0933"},{"key":"2023091409501492000_64.9.1439.23","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.187021"},{"key":"2023091409501492000_64.9.1439.24","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00259-015-3254-8","article-title":"Theranostic pretargeted radioimmunotherapy of colorectal cancer xenografts in mice using picomolar affinity 86Y- or 177Lu-DOTA-Bn binding scFv C825\/GPA33 IgG bispecific immunoconjugates","volume":"43","author":"Cheal","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2023091409501492000_64.9.1439.25","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.113.131037"},{"key":"2023091409501492000_64.9.1439.26","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.263253"},{"key":"2023091409501492000_64.9.1439.27","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3892\/ijo.2012.1463","article-title":"Development and characterization of a preclinical ovarian carcinoma model to investigate the mechanism of acquired resistance to trastuzumab","volume":"41","author":"Luistro","year":"2012","journal-title":"Int J Oncol."},{"key":"2023091409501492000_64.9.1439.28","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.141580"},{"key":"2023091409501492000_64.9.1439.29","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2012.1281"},{"key":"2023091409501492000_64.9.1439.30","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262123"},{"key":"2023091409501492000_64.9.1439.31","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.208348"},{"key":"2023091409501492000_64.9.1439.32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/14736691211060117","article-title":"ICRU report 96, dosimetry-guided radiopharmaceutical therapy","volume":"21","author":"Sgouros","year":"2021","journal-title":"J ICRU."},{"key":"2023091409501492000_64.9.1439.33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00259-021-05583-x","article-title":"Imaging and dosimetry for alpha-particle emitter radiopharmaceutical therapy: improving radiopharmaceutical therapy by looking into the black box","volume":"49","author":"Sgouros","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2023091409501492000_64.9.1439.34","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1080\/09553002.2022.2033341","article-title":"212Pb-conjugated anti-rat HER2\/neu antibody against a neu-N derived murine mammary carcinoma cell line: cell kill and RBE in\u00a0vitro","volume":"98","author":"Liatsou","year":"2022","journal-title":"Int J Radiat Biol."},{"key":"2023091409501492000_64.9.1439.35","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.058651"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.122.265095","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T16:53:53Z","timestamp":1694710433000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.122.265095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,22]]},"references-count":35,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9,1]]},"published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.2967\/jnumed.122.265095"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.122.265095","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,22]]}}}